FDA agreed that data from the Phase 2a diSArm study support advancement of AP-SA02 to a Phase 3study First bacteriophage company to advance a clinical candidate to ...
In the weightless void of the International Space Station, viruses underwent a transformation that could redefine the fight ...
Morning Overview on MSN
AI designs a custom virus to hunt and destroy deadly E coli
Artificial intelligence has crossed a new threshold in biology, helping design viruses that can seek out and kill drug resistant bacteria such as dangerous strains of E. coli. Instead of discovering ...
It is a great pleasure to announce that Professor Robert T. Schooley, from the University of California, San Diego (USA), will be a keynote speaker at the 8th World Congress on Targeting Phage Therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results